Castration-resistant prostate cancer: potential targets and therapies

The treatment landscape for patients with castration-resistant prostate cancer (CRPC) is undergoing significant changes with the advent of new therapies and multidisciplinary efforts by scientists and clinicians. As activation of multiple molecular pathways in the neoplastic prostate makes it imposs...

Descripción completa

Detalles Bibliográficos
Autores principales: Parray, Aijaz, Siddique, Hifzur R, Nanda, Sanjeev, Konety, Badrinath R, Saleem, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3430091/
https://www.ncbi.nlm.nih.gov/pubmed/22956858
http://dx.doi.org/10.2147/BTT.S23954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3430091/
https://www.ncbi.nlm.nih.gov/pubmed/22956858
http://dx.doi.org/10.2147/BTT.S23954

Ejemplares similares